InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is on a quest to redefine the life of the spinal cord injury patient. Armed with cutting-edge technology and MIT science, experienced business and medical professionals at InVivo Therapeutics are pushing the boundaries of spinal cord injury research. As the recognized leader in the SCI field, the company has a singular focus: improving quality-of-life — and redefining life — for the SCI patients it serves. For more information, visit the company’s website at www.invivotherapeutics.com.